Uni-Bio Science Group Limited
UNBSF
$0.004
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 12.64M | 10.85M | 9.05M | 8.56M | 8.07M |
| Total Depreciation and Amortization | 2.51M | 2.31M | 2.10M | 1.83M | 1.57M |
| Total Amortization of Deferred Charges | 56.20K | 56.20K | 56.20K | 57.50K | 58.70K |
| Total Other Non-Cash Items | -697.50K | -217.20K | 262.30K | 438.00K | 610.70K |
| Change in Net Operating Assets | 1.16M | 1.16M | 1.16M | -142.30K | -1.44M |
| Cash from Operations | 15.67M | 14.15M | 12.63M | 10.75M | 8.87M |
| Capital Expenditure | -7.64M | -7.64M | -7.64M | -5.63M | -3.63M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 6.60K | 13.20K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.15M | -3.12M | -2.09M | -2.02M | -1.95M |
| Cash from Investing | -11.79M | -10.76M | -9.73M | -7.65M | -5.57M |
| Total Debt Issued | 45.66M | 45.66M | 45.66M | 30.45M | 15.24M |
| Total Debt Repaid | -15.04M | -15.04M | -15.04M | -9.43M | -3.83M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -5.17M | -5.17M | -5.17M | -2.58M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 23.75M | 11.40M | -941.00K | -4.12M | -7.29M |
| Cash from Financing | 6.29M | 4.71M | 3.13M | 1.83M | 525.10K |
| Foreign Exchange rate Adjustments | -2.74M | -2.40M | -2.07M | -2.06M | -2.05M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.43M | 5.70M | 3.97M | 2.87M | 1.77M |